Vera Therapeutics, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 15 →Insiders1 insider bought $249,985 in 1 open-market buy. 8 insiders sold $5.7M, 10 of 19 sales on a 10b5-1 plan.→HoldersBlackRock 8.0%Avoro Capital 8.0%State Street 5.8%→PeersClosest companies: VRDN, MREO, ROIV→
From the filings
Figures
- Net income
- −$401.9Mlast 12 months
- Operating cash flow
- −$293.2Mlast 12 months
- Cash and equivalents
- $48.9Mat the last balance sheet
- Total debt
- $75.2Mat the last balance sheet
- Shares outstanding
- 71.8M shareson issue